BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Chromos

Chromos is a biopharmaceutical company with two drug development programs focused on inflammatory diseases and thrombotic disorders.
BUSINESS FOCUS Developing biological therapies for the treatment of multiple sclerosis (MS), thrombotic disorders and other inflammatory diseases .

PROPRIETARY PRODUCTS Two humanized monoclonal antibodies with novel mechanisms of action. CHR-1103 is being developed initially to treat multiple sclerosis. CHR-1201 is being developed to treat acute thrombosis

PROPRIETARY PLATFORMS The ACE System and REM technology.

BUSINESS STRATEGY Advance CHR-1103 and CHR-1201 into the clinic, supporting the product development program with revenues generated from licensing proprietary platforms.


Contact Details:
8081 Lougheed Highway
Burnaby
British Columbia
V5A 1W9
Canada
Tel:
Fax:
Email:
WWW:

www.chromos.com/




Loading...

Recent Publications by Chromos:

Impact of non-profit organizations on drug discovery: opportunities, gaps, solutions.
Non-profit organizations (NPO) play an increasingly important role in drug...
3rd October, 2008
Novartis Institute for Tropical Diseases, 10 Biopolis Road, #05-01 Drug Discov Today. 2008 Apr;13(7-8):347-52.
DOI Direct Link
A scintillation proximity assay for dengue virus NS5 2'-O-methyltransferase-Kinetic and inhibition analyses.
Dengue virus (DENV) NS5 possesses methyltransferase (MTase) activity at...
24th September, 2008
Novartis Institute for Tropical Diseases, 10 Biopolis Road, #05-01 Antiviral Res. 2008 Sep 19.
DOI Direct Link
The protonmotive force is required for maintaining ATP homeostasis and viability of hypoxic, nonreplicating Mycobacterium tuberculosis.
The persistence of Mycobacterium tuberculosis despite prolonged...
17th September, 2008
Novartis Institute for Tropical Diseases, 10 Biopolis Road, #05-01 Proc Natl Acad Sci U S A. 2008 Aug 19;105(33):11945-50. Epub 2008 Aug 12.
DOI Direct Link
Towards the design of antiviral inhibitors against flaviviruses: The case for the multifunctional NS3 protein from Dengue virus as a target.
New treatments are urgently needed to combat the increasing number of...
5th August, 2008
School of Biological Sciences, Nanyang Technological University, 60 Antiviral Res. 2008 Jul 30.
DOI Direct Link
Recombinase-based reporter system and antisense technology to study gene expression and essentiality in hypoxic nonreplicating mycobacteria.
The study of the mechanisms used by Mycobacterium tuberculosis to survive...
25th July, 2008
Novartis Institute for Tropical Diseases, Chromos, Singapore. FEMS Microbiol Lett. 2008 Jul;284(1):68-75.
DOI Direct Link

View more Chromos research publications.

BioNews Results for Chromos:

Chromos Announces Timing of Closing of Arrangement
Pharma Live:  Sep 24 2008 1:06PM Matching: chromos
Chromos announces timing of closing of Arrangement
NewsBlaze:  Sep 23 2008 11:10PM Matching: chromos
Chromos announces timing of closing of Arrangement
KOTA Territory News:  Sep 23 2008 11:05PM Matching: chromos
Chromos announces timing of closing of Arrangement
Montana's News Station:  Sep 24 2008 11:58AM Matching: chromos
Chromos announces timing of closing of Arrangement
KLFY:  Sep 24 2008 7:09AM Matching: chromos
Promote your company here: BioNewsCast - Press Release Distribution

View more Chromos news.

Chromos Patents:

US Patent No.Title
7294511 Methods for delivering nucleic acid molecules into cells and assessment thereof
6936469 Methods for delivering nucleic acid molecules into cells and assessment thereof
6743967 Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
6077697 Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
6025155 Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes

View more Chromos patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 219 times since April 2007, the link to the organisation's website has been followed 34 times

Recent Search Terms used to find this page: chromos.com | chromos.com | .

Search for more companies in Burnaby

Search for more companies in British Columbia



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Chromos
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.